3 Faza badań retatrutydu - badanie Triumf 4

Cytat

Skrót:

https://www.prnewswire.com/news-releases/lillys-triple-agonist-retatrutide-delivered-weight-loss-of-up-to-an-average-of-71-2-lbs-along-with-substantial-relief-from-osteoarthritis-pain-in-first-successful-phase-3-trial-302638804.html

Szersze omówienie:

https://www.nejm.org/doi/full/10.1056/NEJMoa2301972

inthepinkk@protonmail.com

Przewijanie do góry